- Home
- JJSF vs DNLI Comparison
JJSF vs DNLI Comparison
Compare JJSF & DNLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JJSF
- DNLI
- Stock Information
- Founded
- JJSF 1971
- DNLI 2013
- Country
- JJSF United States
- DNLI United States
- Employees
- JJSF N/A
- DNLI N/A
- Industry
- JJSF Specialty Foods
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JJSF Consumer Staples
- DNLI Health Care
- Exchange
- JJSF Nasdaq
- DNLI Nasdaq
- Market Cap
- JJSF 3.3B
- DNLI 3.3B
- IPO Year
- JJSF N/A
- DNLI 2017
- Fundamental
- Price
- JJSF $159.70
- DNLI $21.56
- Analyst Decision
- JJSF Strong Buy
- DNLI Strong Buy
- Analyst Count
- JJSF 1
- DNLI 11
- Target Price
- JJSF $200.00
- DNLI $40.40
- AVG Volume (30 Days)
- JJSF 86.2K
- DNLI 965.5K
- Earning Date
- JJSF 02-03-2025
- DNLI 11-06-2024
- Dividend Yield
- JJSF 1.89%
- DNLI N/A
- EPS Growth
- JJSF 9.07
- DNLI N/A
- EPS
- JJSF 4.45
- DNLI N/A
- Revenue
- JJSF $1,574,755,000.00
- DNLI N/A
- Revenue This Year
- JJSF $5.79
- DNLI N/A
- Revenue Next Year
- JJSF $3.60
- DNLI $420.35
- P/E Ratio
- JJSF $35.98
- DNLI N/A
- Revenue Growth
- JJSF 1.02
- DNLI 204.74
- 52 Week Low
- JJSF $133.23
- DNLI $14.56
- 52 Week High
- JJSF $180.80
- DNLI $33.33
- Technical
- Relative Strength Index (RSI)
- JJSF 32.83
- DNLI 31.61
- Support Level
- JJSF $159.96
- DNLI $22.61
- Resistance Level
- JJSF $169.42
- DNLI $24.15
- Average True Range (ATR)
- JJSF 3.54
- DNLI 1.12
- MACD
- JJSF -1.22
- DNLI -0.19
- Stochastic Oscillator
- JJSF 5.05
- DNLI 13.47
About JJSF J & J Snack Foods Corp.
J&J Snack Foods Corp manufactures, markets, and distributes snack foods and beverages to foodservice and retail supermarket outlets. The company's products include frozen beverages, juice, fruit bars, sorbet, cakes, and cookies that are distributed to various consumers, including restaurants, supermarkets, convenience stores, universities, theaters, and theme parks. The company operates in three business segments: food service, which sells snacks, desserts, and baked goods at the point-of-sale; retail supermarkets, which sells frozen and prepackaged products to supermarkets; and frozen beverages, which sells frozen beverages under brands Icee, Slush puppie, and Parrot ice in the United States, Mexico, and Canada.
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.